Retrieve available abstracts of 53 articles: HTML format
Single Articles
December 2025
MAJAHA M, Chikwari CD, Kizito S, Moyo D, et al HIV and alcohol misuse among miners in Zimbabwe.
Lancet. 2025;404:2538. PubMed
July 2025
LAZARUS JV, Bansal MB, Kanwal F, Lofton H, et al Reflections on the Lancet Commission on Investing in Health's Global Health 2050
report.
Lancet. 2025;406:30-31. PubMed
HALLETT TB, Menzies NA, Resch S, Pretorius C, et al The case for optimal investment in combating HIV, tuberculosis, and malaria: a
global modelling study.
Lancet. 2025 Jul 3:S0140-6736(25)00831-1. doi: 10.1016/S0140-6736(25)00831. PubMedAbstract available
June 2025
CAVALCANTI DM, de Oliveira Ferreira de Sales L, da Silva AF, Basterra EL, et al Evaluating the impact of two decades of USAID interventions and projecting the
effects of defunding on mortality up to 2030: a retrospective impact evaluation
and forecasting analysis.
Lancet. 2025 Jun 30:S0140-6736(25)01186-9. doi: 10.1016/S0140-6736(25)01186. PubMedAbstract available
RAO S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, et al Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic
squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global,
phase 3 randomised controlled trial.
Lancet. 2025;405:2144-2152. PubMedAbstract available
BOZICEVIC I, Oreskovic S, van der Graaf R, McKee M, et al Open letter in support of WHO.
Lancet. 2025 Jun 13:S0140-6736(25)01174-2. doi: 10.1016/S0140-6736(25)01174. PubMed
May 2025
SHIU C, Ho J, Aung MN, Chen WT, et al From disappointment to despair: USAID cuts to Myanmar's HIV services.
Lancet. 2025 May 1:S0140-6736(25)00714-7. doi: 10.1016/S0140-6736(25)00714. PubMed
April 2025
ROSA WE, Connor S, Aggarwal G, Alsirafy S, et al Relieve the suffering: palliative care for the next decade.
Lancet. 2025 Apr 18:S0140-6736(25)00678-6. doi: 10.1016/S0140-6736(25)00678. PubMed
UNEMO M, Wi T Gepotidacin shows promise for the treatment of uncomplicated gonorrhoea.
Lancet. 2025 Apr 11:S0140-6736(25)00680-4. doi: 10.1016/S0140-6736(25)00680. PubMed
ROSS JDC, Wilson J, Workowski KA, Taylor SN, et al Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea
(EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
Lancet. 2025 Apr 11:S0140-6736(25)00628-2. doi: 10.1016/S0140-6736(25)00628. PubMedAbstract available
NDEMBI N, Karuna S, Cowden J, Cagigi A, et al Accelerating vaccine development in Africa: lessons from HIV research.
Lancet. 2025 Apr 10:S0140-6736(25)00564-1. doi: 10.1016/S0140-6736(25)00564. PubMed
SIDIBE M, Makgoba TC, Paul B, Brilliant B, et al Accelerating domestic investments to end AIDS in Africa.
Lancet. 2025 Apr 8:S0140-6736(25)00685-3. doi: 10.1016/S0140-6736(25)00685. PubMed
CLUVER L, Makangila G, Hillis S, Ntwali-N'Konzi JP, et al Protecting Africa's children from extreme risk: a runway of sustainability for
PEPFAR programmes.
Lancet. 2025 Apr 8:S0140-6736(25)00401-5. doi: 10.1016/S0140-6736(25)00401. PubMedAbstract available
OKANO JT, Blower S Long-acting HIV preventive treatments for remote rural communities.
Lancet. 2025;405:1143. PubMed
March 2025
AL ZAMEL AM, Saeed AA, Elmubarak M Sudan's war and the burden of HIV: a call for urgent intervention.
Lancet. 2025 Mar 27:S0140-6736(25)00547-1. doi: 10.1016/S0140-6736(25)00547. PubMed
PRASAD A Rachael Burke: integrating equitable HIV and TB research and care.
Lancet. 2025 Mar 17:S0140-6736(25)00515-X. doi: 10.1016/S0140-6736(25)00515. PubMed
PRASAD A Aliasgar Esmail: innovation in TB and HIV research and medicine.
Lancet. 2025 Mar 17:S0140-6736(25)00514-8. doi: 10.1016/S0140-6736(25)00514. PubMed
JOGIRAJU V, Pawar P, Yager J, Ling J, et al Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label
study.
Lancet. 2025 Mar 10:S0140-6736(25)00405-2. doi: 10.1016/S0140-6736(25)00405. PubMedAbstract available
RYOM L The potential for annual long-acting HIV pre-exposure prophylaxis.
Lancet. 2025 Mar 10:S0140-6736(25)00452-0. doi: 10.1016/S0140-6736(25)00452. PubMed
BARMANIA S Research focus: Institute of HIV Research and Innovation.
Lancet. 2025;405:771. PubMed
TRAJMAN A, Campbell JR, Kunor T, Ruslami R, et al Tuberculosis.
Lancet. 2025;405:850-866. PubMedAbstract available
February 2025
DEVI S A new era for HIV in the Philippines?
Lancet. 2025;405:611-612. PubMed
HOLT E Ukraine HIV services severely curtailed by US aid freeze.
Lancet. 2025;405:455. PubMed
RATEVOSIAN J, Millett G, Honermann B, Bennett S, et al PEPFAR under review: what's at stake for PEPFAR's future.
Lancet. 2025 Feb 7:S0140-6736(25)00258-2. doi: 10.1016/S0140-6736(25)00258. PubMed
January 2025
BROSIUS I, Vakaniaki EH, Mukari G, Munganga P, et al Epidemiological and clinical features of mpox during the clade Ib outbreak in
South Kivu, Democratic Republic of the Congo: a prospective cohort study.
Lancet. 2025 Jan 29:S0140-6736(25)00047-9. doi: 10.1016/S0140-6736(25)00047. PubMedAbstract available
KAMAL-YANNI M, Gangte L, Kittitrakul C, Meyer S, et al Is MSF changing course on access to medicines?
Lancet. 2025;405:124-125. PubMed
November 2024
THE LANCET Triumphs and threats: HIV in 2024.
Lancet. 2024;404:2131. PubMed
BENDER IGNACIO RA, Shapiro AE, Montano MA, Titanji BK, et al An urgent call to address the intersection of mpox and HIV in Africa.
Lancet. 2024 Nov 28:S0140-6736(24)02542-X. doi: 10.1016/S0140-6736(24)02542. PubMed
NORHEIM OF, Chang AY, Bolongaita S, Barraza-Llorens M, et al Halving premature death and improving quality of life at all ages: cross-country
analyses of past trends and future directions.
Lancet. 2024 Nov 20:S0140-6736(24)02417-6. doi: 10.1016/S0140-6736(24)02417. PubMedAbstract available
COUSINS S New HIV drugs: access debates.
Lancet. 2024;404:1797-1798. PubMed
September 2024
SALEH E, Dousa KM, Babiker A, Rahma NEAA, et al Health and humanitarian toll of Sudan's forgotten war.
Lancet. 2024 Sep 24:S0140-6736(24)01939-1. doi: 10.1016/S0140-6736(24)01939. PubMed
August 2024
KIZITO S, Nabayinda J, Nabunya P, Ssewamala FM, et al HIV and tuberculosis in Uganda: are we neglecting poverty?
Lancet. 2024;404:844-845. PubMed
BASSEY AE The health of migrants at the intersection of mpox and HIV.
Lancet. 2024 Aug 23:S0140-6736(24)01753-7. doi: 10.1016/S0140-6736(24)01753. PubMed
MODY A, Sohn AH, Iwuji C, Tan RKJ, et al The battle against paediatric HIV is far from over - Authors' reply.
Lancet. 2024;404:522-523. PubMed
VAN DE PERRE P, Tylleskar T The battle against paediatric HIV is far from over.
Lancet. 2024;404:522. PubMed
NABAYINDA J, Kizito S, Nagawa A, Ssewamala FM, et al Reducing HIV in young women in Uganda: the need for autonomy.
Lancet. 2024;404:519-520. PubMed
SALEEM SM, Haq Z Bridging gaps in vertical transmission of HIV, syphilis, and hepatitis B in
India.
Lancet. 2024;404:428-429. PubMed
July 2024
KIRBY T Beatriz Grinsztejn: leading Brazil's response to HIV.
Lancet. 2024;404:233. PubMed
May 2024
JAFFAR S Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors'
reply.
Lancet. 2024;403:2292. PubMed
CAI S, Xu Z, Zhao Y, Zuhlke L, et al Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
Lancet. 2024;403:2291. PubMed
HAVLIR D, Kamya MR, Petersen M Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
Lancet. 2024;403:2291-2292. PubMed
MAERTENS GN, Purcell DFJ, Rosadas C, Bradshaw D, et al Why not eliminate HTLV-1 while eliminating HIV-1?
Lancet. 2024;403:2288-2289. PubMed
The HIV response beyond 2030: preparing for decades of sustained HIV epidemic
control in eastern and southern Africa.
Lancet. 2024 May 20:S0140-6736(24)00980-2. doi: 10.1016/S0140-6736(24)00980. PubMed
LEWNARD JA, Charani E, Gleason A, Hsu LY, et al Burden of bacterial antimicrobial resistance in low-income and middle-income
countries avertible by existing interventions: an evidence review and modelling
analysis.
Lancet. 2024 May 20:S0140-6736(24)00862-6. doi: 10.1016/S0140-6736(24)00862. PubMedAbstract available
MENDELSON M, Lewnard JA, Sharland M, Cook A, et al Ensuring progress on sustainable access to effective antibiotics at the 2024 UN
General Assembly: a target-based approach.
Lancet. 2024 May 20:S0140-6736(24)01019-5. doi: 10.1016/S0140-6736(24)01019. PubMedAbstract available
April 2024
TUTLAM NT, Kizito S, Liyew TW, Ssewamala FM, et al HIV among refugee youth in Uganda: unmasking the crisis.
Lancet. 2024;403:1536-1537. PubMed
Global incidence, prevalence, years lived with disability (YLDs),
disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for
371 diseases and injuries in 204 countries and territories and 811 subnational
locations, 1990-2021: a sys
Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757. PubMedAbstract available
Global burden of 288 causes of death and life expectancy decomposition in 204
countries and territories and 811 subnational locations, 1990-2021: a systematic
analysis for the Global Burden of Disease Study 2021.
Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367. PubMedAbstract available
March 2024
BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al Under threat: the International AIDS Society-Lancet Commission on Health and
Human Rights.
Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302. PubMed
WATTS G Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539. PubMed
KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso
(PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464. PubMedAbstract available
MUTALE W, Herce ME Closing the gap in paediatric HIV infections: how available tools and technology
can accelerate progress towards ending AIDS by 2030.
Lancet. 2024 Mar 11:S0140-6736(24)00366-0. doi: 10.1016/S0140-6736(24)00366. PubMed
Global age-sex-specific mortality, life expectancy, and population estimates in
204 countries and territories and 811 subnational locations, 1950-2021, and the
impact of the COVID-19 pandemic: a comprehensive demographic analysis for the
Global Burden
Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476. PubMedAbstract available